Mylan N.V.

Lawsuit Filings

Class Action Claims Mylan, Pfizer Manipulated EpiPen Expiration Dates to Increase Sales [UPDATE]

March 6, 2020 A proposed class action alleges the makers of EpiPen have intentionally manipulated expiration dates in order to force consumers to refill their prescriptions more often.

Class Action Alleges Mylan, Rite Aid Continued to Sell Contaminated High Blood Pressure Drug Despite Sweeping Recalls

December 11, 2018 Mylan and Rite Aid are facing a class action that claims the companies respectively manufactured and sold generic valsartan medications despite possessing knowledge that the drugs were contaminated with probable carcinogen N-nitrosodiethylamine (NDEA).